AB Akola Group, company code: 148030011, address of the head office: Subaciaus str. 5, LT-01302 Vilnius, Lithuania. AB Akola Group invites shareholders, investors, analysts and other stakeholders to join its investor webinar for the 9 months results of the financial year 2025/2026, scheduled on May 21st, 2026 at 9:00 am (EET). The language of the event is English. The webinar will be hosted by the Deputy CEO for Finance and Investments of the company Mažvydas Šileika who will introduce the financial results and comment on the recent developments in the company. After the presentation, investors are welcome to ask questions. We encourage attendees to send their questions before the webinar until May 20th, 2026 to Olga.Azarova@nasdaq.com. How to join the webinar? To join the webinar, please register via following link: https://nasdaq.zoom.us/webinar/register/7717781502029/WN_kXlsjCZUQTOPfzCZ5nTdVQ You...

May 12, 2026  News release BioPorto A/S to host an investor webcast on the results for the first quarter of 2026  COPENHAGEN, DENMARK, May 12, 2026 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), announced today that CEO Carsten Buhl and CFO Klaus Juhl Wulff will present financial results for the first quarter of 2026 at a webcast for investors on May 21, 2026 at 11:00 AM CET.   Registration for the presentation is now open, and participants can submit questions in advance. Please register at the following link: Q1 trading update  To receive BioPorto’s Company Announcements, Press Releases, Newsletters and other business relevant information, please sign up on https://bioporto.com/investor-contact/.    Investor Relations Contact  Klaus Juhl Wulff, Investor Relations, BioPorto A/S, investor@bioporto.com, C: +45...

                                        Regulated information May 12, 2026 – 7:45 a.m. CET        Agfa-Gevaert delivers robust Q1 2026 performance amid market challengesGroup performance:Revenue growth: top line up 1.7% excluding currency impact in a seasonally weaker quarter, driven by silver price uplifts in film and a step-up in Digital Printing Solutions Profitability increase: strong adjusted EBITDA of 12 million euro, mainly due to savings programs and the ability to pass on the silver price impact to customers Cash flow impact: negative free cash flow of -42 million euro in Q1, primarily due to a 33 million euro increase in working capital (41 million euro impact from silver price) and the transformation cash-out. Not taking into account the impact of the silver price, all businesses continued to show working capital...

Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with a single‑assay design, intended to rule in and rule out amyloid pathology across primary and secondary care, offering faster diagnosis for millions of patients around the world.1,2,5 While maintaining accuracy comparable to spinal fluid diagnostics against the gold standard PET-CT scans, the Elecsys® pTau217 test offers a more convenient, minimally invasive alternative via a routine blood draw.1,2,4,7,8,11 Diagnosing dementia currently takes 3.5 years on average,11 and an estimated 75% of people living with dementia remain undiagnosed.6,9,11 Elecsys® pTau217 offers a simple blood test to aid in earlier, more accessible Alzheimer’s disease diagnosis for millions of patients around the world.1,2,4,5,7,8Basel, 12 May 2026 – Roche (SIX: RO, ROP;...

A partnership deployed in International Markets including Africa, Asia Pacific, Middle East, Turkey, South & Southeast Europe and Switzerland. Paris, France, and Dubai, United Arab Emirates, May 12, 2026 — Atos, a global leader in AI-powered digital transformation, today announced the signing of a Master Collaboration Agreement with Backbase, the creator of the AI-Native Banking OS. The agreement strengthens collaboration between the two companies to support financial institutions in accelerating AI-native transformation while maintaining control, compliance, and resilience in increasingly complex and regulated environments across International Markets including Africa, Asia Pacific, Middle East, Portugal, Spain, Southeast Europe, Switzerland and Turkey. As Financial institutions are under increasing pressure to innovate with AI...

BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) — North American lithium producer Elevra Lithium Limited (“Elevra or Company”) (ASX:ELV; NASDAQ:ELVR) announced today the outcomes of an Updated Scoping Study for expansion of the existing North American Lithium (NAL) mine. Relative to the study from 15 September 20251 this study delivers additional annual concentrate production two years faster than originally planned, similar unit operating costs and unchanged total capital expenditure of US$270 million. HighlightsProcess plant design feed rate increased to the permitted average annual 4,500 tonnes per day (tpd) in Stage 1 and 6,500 tpd in Stage 2; average Life of Mine (LOM) recovery of 71.2%; spodumene concentrate at grade of 5.4% Li2O.The updated Scoping Study improves the incremental post-tax NPV(8%) of the expansion...

LONDON, May 12, 2026 (GLOBE NEWSWIRE) — Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech company advancing wellness through evidence-based, personalized nutrition solutions, today announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information...